214 related articles for article (PubMed ID: 16352706)
21. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
[TBL] [Abstract][Full Text] [Related]
22. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
[TBL] [Abstract][Full Text] [Related]
24. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Lichtman AH; Shelton CC; Advani T; Cravatt BF
Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
[TBL] [Abstract][Full Text] [Related]
25. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.
Basavarajappa BS; Nagre NN; Xie S; Subbanna S
Hippocampus; 2014 Jul; 24(7):808-18. PubMed ID: 24648181
[TBL] [Abstract][Full Text] [Related]
26. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
Hiley CR; Hoi PM
Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
Palmer JA; Higuera ES; Chang L; Chaplan SR
Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.
Morena M; Aukema RJ; Leitl KD; Rashid AJ; Vecchiarelli HA; Josselyn SA; Hill MN
J Neurosci; 2019 Feb; 39(7):1275-1292. PubMed ID: 30573646
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides.
Quistad GB; Sparks SE; Casida JE
Toxicol Appl Pharmacol; 2001 May; 173(1):48-55. PubMed ID: 11350214
[TBL] [Abstract][Full Text] [Related]
32. A second fatty acid amide hydrolase with variable distribution among placental mammals.
Wei BQ; Mikkelsen TS; McKinney MK; Lander ES; Cravatt BF
J Biol Chem; 2006 Dec; 281(48):36569-78. PubMed ID: 17015445
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
Chang L; Luo L; Palmer JA; Sutton S; Wilson SJ; Barbier AJ; Breitenbucher JG; Chaplan SR; Webb M
Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
[TBL] [Abstract][Full Text] [Related]
34. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.
Solinas M; Justinova Z; Goldberg SR; Tanda G
J Neurochem; 2006 Jul; 98(2):408-19. PubMed ID: 16805835
[TBL] [Abstract][Full Text] [Related]
35. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.
Patel S; Wohlfeil ER; Rademacher DJ; Carrier EJ; Perry LJ; Kundu A; Falck JR; Nithipatikom K; Campbell WB; Hillard CJ
Br J Pharmacol; 2003 Jul; 139(5):1005-13. PubMed ID: 12839875
[TBL] [Abstract][Full Text] [Related]
36. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.
Clement AB; Hawkins EG; Lichtman AH; Cravatt BF
J Neurosci; 2003 May; 23(9):3916-23. PubMed ID: 12736361
[TBL] [Abstract][Full Text] [Related]
37. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
38. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
Egertová M; Cravatt BF; Elphick MR
Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.
Goonawardena AV; Sesay J; Sexton CA; Riedel G; Hampson RE
Neuropharmacology; 2011; 61(5-6):1016-25. PubMed ID: 21767554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]